Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Ionis Pharmaceuticals Inc Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 6,135 shares of IONS stock, worth $204,418. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,135
Previous 5,654
8.51%
Holding current value
$204,418
Previous $197,000
6.09%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$546 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$539 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$412 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$344 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$280 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.73B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...